Showing results (1911-1920 of 2,173) with videos related to

Sort By:
Pageof 218
Proteomics|May 7, 2011
A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analysesMatthew P Welberry Smith, Steven L Wood, Alexandre Zougman, et al.
Leukemia & Lymphoma|June 27, 2009
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trialAzra Raza, Joseph G Jurcic, Gail J Roboz, et al.
The Journal of Organic Chemistry|December 19, 2012
Toward the synthesis of phomoidride DGraham K Murphy, Tatsuya Shirahata, Naoto Hama, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell TransplantationMatthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 1997
Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patientsT F Logan, W E Gooding, T L Whiteside, et al.
Substance Use & Misuse|December 20, 2021
Exploring Patterns of the Use of Electronic Nicotine Delivery Systems among Adolescents in High-Risk Appalachian (U.S.A) CommunitiesHadii M Mamudu, Disha Shahani, Antwan Jones, et al.
Leukemia|January 25, 2020
Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AMLLinde M Morsink, Megan Othus, Evandro D Bezerra, et al.
Blood|November 29, 2007
Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapyJohn M Pagel, Nathan Hedin, Lacey Drouet, et al.
Stem Cell Reports|March 26, 2019
Insulin-like Growth Factor II: An Essential Adult Stem Cell Niche Constituent in Brain and IntestineAmber N Ziegler, Qiang Feng, Shravanthi Chidambaram, et al.
Leukemia|June 4, 2014
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantationR B Walter, B Gyurkocza, B E Storer, et al.
Pageof 218